Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical (LFCR) Income towards Parent Company: 2009-2025

Historic Income towards Parent Company for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to -$38.7 million.

  • Lifecore Biomedical's Income towards Parent Company fell 38333.33% to -$1.1 million in Q2 2025 from the same period last year, while for May 2025 it was -$38.7 million, marking a year-over-year decrease of 1543.59%. This contributed to the annual value of -$38.7 million for FY2025, which is 1543.59% down from last year.
  • Lifecore Biomedical's Income towards Parent Company amounted to -$38.7 million in FY2025, which was down 1,543.59% from $2.7 million recorded in FY2024.
  • Lifecore Biomedical's 5-year Income towards Parent Company high stood at $2.7 million for FY2024, and its period low was -$101.9 million during FY2022.
  • Moreover, its 3-year median value for Income towards Parent Company was -$35.3 million (2023), whereas its average is -$23.8 million.
  • As far as peak fluctuations go, Lifecore Biomedical's Income towards Parent Company skyrocketed by 107.59% in 2024, and later plummeted by 1,543.59% in 2025.
  • Over the past 5 years, Lifecore Biomedical's Income towards Parent Company (Yearly) stood at -$10.3 million in 2021, then tumbled by 890.66% to -$101.9 million in 2022, then soared by 65.34% to -$35.3 million in 2023, then spiked by 107.59% to $2.7 million in 2024, then slumped by 1,543.59% to -$38.7 million in 2025.